Restless Legs Syndrome Market Share

Market Share of Restless Legs Syndrome Industry

The restless legs syndrome market is moderately fragmented in nature due to the presence of several companies operating globally and regionally. The competitive landscape includes analyzing companies Azurity Pharmaceuticals, LLC, Glenmark Pharmaceutical, UCB S.A., Sun Pharmaceutical Industries Ltd, Boehringer Ingelheim International GmbH, Relegs, Restiffic, Viatris Inc., Psychocare Health Private Limited, and Noctrix Health, Inc. among others.

Restless Legs Syndrome Market Leaders

1. UCB S.A

2. Sun Pharmaceutical Industries Ltd 

3. Boehringer Ingelheim International GmbH 

4. Relegs

5. Azurity Pharmaceuticals, LLC

*Disclaimer: Major Players sorted in no particular order